{"id":"tianshu-capsule","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL206253","moleculeType":"Small molecule","molecularWeight":"578.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tianshu is a polyherbal preparation used in Chinese medicine that combines multiple botanical extracts to enhance anti-tumor immunity and induce programmed cell death in malignant cells. The exact molecular targets remain incompletely characterized in Western pharmacological terms, though the formulation is believed to work through immunomodulation and direct cytotoxic effects. It is marketed primarily in China for cancer supportive care and adjunctive treatment.","oneSentence":"Tianshu capsule is a traditional Chinese medicine formulation that modulates immune function and promotes apoptosis in cancer cells through multiple herbal components.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:12:36.903Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Adjunctive treatment in cancer patients"},{"name":"Cancer-related fatigue and immune support"}]},"trialDetails":[{"nctId":"NCT07152860","phase":"NA","title":"Evaluation of the Efficacy of Electroacupuncture in the Treatment of Chronic Atrophic Gastritis","status":"NOT_YET_RECRUITING","sponsor":"Yi Liang","startDate":"2025-12-30","conditions":"Chronic Atrophic Gastritis","enrollment":100},{"nctId":"NCT02035111","phase":"PHASE4","title":"A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.","status":"COMPLETED","sponsor":"Jiangsu Kanion Pharmaceutical Co., Ltd","startDate":"2014-03","conditions":"Migraine","enrollment":947}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Tianshu capsule","genericName":"Tianshu capsule","companyName":"Jiangsu Kanion Pharmaceutical Co., Ltd","companyId":"jiangsu-kanion-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"The Tianshu capsule is a small molecule that acts as a neurokinin 1 receptor antagonist, classified as an antagonist. It has been studied in clinical trials for the treatment of migraine and chronic atrophic gastritis, with one trial specifically evaluating its safety and efficacy in treating migraine.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}